• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Siemens Ultrasound takes on risk-sharing

Article

While many medical imaging vendors talk about partnering withcustomers, one ultrasound vendor believes that a financial risk-sharingarrangement can also prove profitable. Siemens Ultrasound of Issaquah, WA, announced in January thatit has reached an

While many medical imaging vendors talk about partnering withcustomers, one ultrasound vendor believes that a financial risk-sharingarrangement can also prove profitable.

Siemens Ultrasound of Issaquah, WA, announced in January thatit has reached an equipment purchasing agreement with the ClevelandClinic Foundation that will allow CCF to pay for new scannerson a sliding fee based on equipment usage.

Under the exclusive five-year agreement, Siemens will provideCCF with an entirely new ultrasound department, consisting initiallyof six Sonoline Elegra and two Sonoline Versa ultrasound systems.Siemens will also service and upgrade the new scanners and providemore systems as CCF's needs dictate, according to the company.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.